China's Botox boom a boon for HK firm
Union Medical forecasts mainland's medical aesthetics market to double to US$11.3b by 2020
Add BT as a preferred sourceHong Kong
FRETTING about frown lines and crow's feet can start early. In China, women in their 20s and 30s are spending on therapies to smooth their wrinkles - a growing trend Union Medical Healthcare wants to meet.
Union Medical, Hong Kong's biggest provider of the wrinkle treatment Botox, raised HK$742.4 million (S$131 million) in an initial public offering earlier this month to fund acquisitions and capital expenditure that will expand its network of Dr Reborn clinics in the territory and on the mainland.
Share with us your feedback on BT's products and services
TRENDING NOW
Buyer for England striker Harry Kane’s former mansion must pay £3.4 million after abandoning deal
Ohmyhome Ltd sells real estate business for token US$1 due to poor business and continued losses
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
